Abstract
For at least two decades, concerns have been raised about inappropriate psychotropic prescribing in Australian residential aged care facilities, due to their modest therapeutic benefit and increased risk of falls and mortality. To date, the majority of prevalence data has been collected in Sydney exclusively and it is not known if recent initiatives to promote appropriate psychotropic prescribing have impacted utilisation. Thus, we aimed to comprehensively analyse psychotropic use in a large national sample of residential aged care facility residents. A cross-sectional, retrospective cohort study of residents from 150 residential aged care facilities distributed nationally during April 2014-October 2015. Antipsychotic, anxiolytic/hypnotic and antidepressant utilisation was assessed, along with anticonvulsant and anti-dementia drug use. Negative binomial regression analysis was used to examine variation in psychotropic use. Full psychotropic prescribing data was available from 11,368 residents. Nearly two-thirds (61%) were taking psychotropic agents regularly, with over 41% prescribed antidepressants, 22% antipsychotics and 22% of residents taking benzodiazepines. Over 30% and 11% were charted for 'prn' (as required) benzodiazep...Continue Reading
References
Jul 17, 1995·The Medical Journal of Australia·J SnowdonP Tremlett
Jul 1, 1997·Nursing Outlook
Jul 3, 2004·Pharmacy World & Science : PWS·Julie A StokesMichael S Roberts
Nov 15, 2005·BMJ : British Medical Journal·Jennifer GlassUsoa E Busto
Jun 2, 2009·Journal of the American Geriatrics Society·Harrison G BloomPhyllis C Zee
Jul 10, 2009·The Cochrane Database of Systematic Reviews·Edmund Lonergan, Jay Luxenberg
Oct 10, 2009·International Psychogeriatrics·Juanita WestburyGregory Peterson
May 12, 2010·Journal of Clinical Pharmacy and Therapeutics·J L WestburyG M Peterson
Mar 25, 2011·International Psychogeriatrics·John SnowdonDivya Vaswani
Aug 4, 2011·BMJ : British Medical Journal·Carol CouplandJulia Hippisley-Cox
Aug 11, 2011·The Australian and New Zealand Journal of Psychiatry·Samantha A HollingworthHarvey A Whiteford
Sep 29, 2011·JAMA : the Journal of the American Medical Association·Alicia Ruelaz MaherPaul G Shekelle
Oct 25, 2011·Journal of the American Medical Directors Association·Richard D BoyceSteven M Handler
Sep 29, 2012·Drugs & Aging·Jolyce BourgeoisRobert H Vander Stichele
Jul 25, 2013·The Medical Journal of Australia·Juanita L Westbury, Gregory M Peterson
Sep 26, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Jacqueline M McMillanJayna M Holroyd-Leduc
Jan 1, 2015·American Journal of Alzheimer's Disease and Other Dementias·Rajesh R Tampi, Deena J Tampi
Jun 11, 2015·International Psychogeriatrics·Sytse U ZuidemaRaymond T C M Koopmans
Jul 15, 2015·Journal of the American Medical Directors Association·Kaisu H PitkalaJ Simon Bell
Nov 4, 2015·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Akshya VasudevMuhammad Mamdani
Apr 15, 2016·European Journal of Clinical Pharmacology·Michael DörksFalk Hoffmann
Aug 24, 2016·BMC Geriatrics·Sabine BjörkDavid Edvardsson
Sep 7, 2016·International Journal of Geriatric Psychiatry·Nicolas FarinaSube Banerjee
Sep 22, 2016·Journal of the American Medical Directors Association·Claudia A CoxCarolien M J van der Linden
Nov 28, 2016·BMC Geriatrics·Lynna ChenEdwin C K Tan
Dec 26, 2016·Neuroepidemiology·Md Mohaimenul IslamSyed-Abdul Shabbir
Apr 12, 2017·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Heidi TaipaleSirpa Hartikainen
Aug 6, 2017·Journal of Medical Internet Research·Tristan LingGregory Peterson
Citations
Jun 19, 2018·The Australian and New Zealand Journal of Psychiatry·Mouna SawanSarah N Hilmer
Dec 7, 2019·Australasian Journal on Ageing·Carmelle PeisahJuanita Breen
Jan 24, 2020·International Psychogeriatrics·Fleur HarrisonHenry Brodaty
Feb 12, 2020·The Medical Journal of Australia·Stephanie L HarrisonMaria C Inacio
Feb 15, 2020·Expert Review of Clinical Pharmacology·Mouna SawanDanijela Gnjidic
Nov 5, 2019·BMJ Open·Diana Velasquez ReyesOsvaldo P Almeida
May 22, 2020·PloS One·Mohammad HamiduzzamanVivian Isaac
Dec 12, 2018·Drugs & Aging·Stephanie L HarrisonHenry Brodaty
Nov 30, 2019·Pharmacy : Journal of Pharmacy, Education and Practice·Mojtaba VaismoradiSue Jordan
Mar 13, 2020·Aging Clinical and Experimental Research·Stephanie L HarrisonMaria C Inacio
Jul 4, 2020·International Psychogeriatrics·Daniel J HoyleJuanita L Breen
Jan 4, 2021·Journal of the American Medical Directors Association·Tien Ngoc Thi BuiVijayaprakash Suppiah
Nov 24, 2020·Journal of Psychoactive Drugs·Diego Zapelini do NascimentoFabiana Schuelter-Trevisol
Sep 21, 2020·Archives of Gerontology and Geriatrics·Katrina Anderson, Annaliese Blair
Apr 8, 2021·Health & Social Care in the Community·Jinfeng DingAngus Cook
May 14, 2021·Aging & Mental Health·Daisy A WigginKieran A Walsh
May 23, 2021·Scientific Reports·Monica CationsMaria C Inacio
May 27, 2021·Aging Clinical and Experimental Research·Kailash ThapaliyaJulie E Byles
Jun 1, 2021·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Claire E SextonMaria C Carrillo
Jun 13, 2021·Trials·Sam KosariRachel Davey
Jul 23, 2020·Journal of the American Medical Directors Association·Lauren B GerlachDonovan T Maust
Nov 12, 2021·Australasian Journal on Ageing·Hend AlmutairiRosemary Saunders
Dec 24, 2021·Internal Medicine Journal·Hend AlmutairiLeon Flicker